Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 17,162 $ 49,724
Other current assets 2,544 2,409
Total current assets 19,706 52,133
Investment in Charter, accounted for using the equity method (note 4) 12,306,593 12,194,674
Other assets 9,100 9,535
Total assets 12,335,399 12,256,342
Current liabilities:    
Accounts payable and accrued liabilities 8,562 6,168
Deferred revenue and other current liabilities 11,544 5,971
Total current liabilities 20,106 12,139
Debt (note 5) 573,593 572,944
Deferred income tax liabilities 1,017,921 999,757
Other liabilities 3,045 3,556
Total liabilities 1,614,665 1,588,396
Equity    
Preferred stock, $.01 par value. Authorized 50,000,000 shares; no shares issued
Additional paid-in capital 7,878,499 7,890,084
Accumulated other comprehensive earnings, net of taxes 8,158 8,158
Retained earnings 2,832,257 2,767,885
Total equity 10,720,734 10,667,946
Commitments and contingencies (note 7)
Total liabilities and equity 12,335,399 12,256,342
Series A common stock    
Equity    
Common stock 265 265
Series B common stock    
Equity    
Common stock 25 25
Series C common stock    
Equity    
Common stock $ 1,530 $ 1,529